NO20100114L - Smakstilsatt leirebasert farmasoytisk preparat - Google Patents

Smakstilsatt leirebasert farmasoytisk preparat

Info

Publication number
NO20100114L
NO20100114L NO20100114A NO20100114A NO20100114L NO 20100114 L NO20100114 L NO 20100114L NO 20100114 A NO20100114 A NO 20100114A NO 20100114 A NO20100114 A NO 20100114A NO 20100114 L NO20100114 L NO 20100114L
Authority
NO
Norway
Prior art keywords
clay
flavored
pharmaceutical preparation
based pharmaceutical
flavor
Prior art date
Application number
NO20100114A
Other languages
English (en)
Inventor
Jerome Barra
Denis Le Hazif
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of NO20100114L publication Critical patent/NO20100114L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)

Abstract

Gjenstanden for foreliggende oppfinnelse er et smakstilsatt terapeutisk preparat inneholdende en leire som aktiv bestanddel og karakterisert ved at leiren er en dioktaedrisk smektitt og smaksstoffet er innkapslet.
NO20100114A 2007-08-13 2010-01-22 Smakstilsatt leirebasert farmasoytisk preparat NO20100114L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07291005A EP2025332A1 (fr) 2007-08-13 2007-08-13 Composition thérapeutique aromatisée à base d'argile
PCT/FR2008/001185 WO2009056703A1 (fr) 2007-08-13 2008-08-12 Composition thérapeutique aromatisée à base d'argile

Publications (1)

Publication Number Publication Date
NO20100114L true NO20100114L (no) 2010-03-10

Family

ID=39052728

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20100114A NO20100114L (no) 2007-08-13 2010-01-22 Smakstilsatt leirebasert farmasoytisk preparat

Country Status (27)

Country Link
US (2) US20100159013A1 (no)
EP (3) EP2025332A1 (no)
JP (2) JP5670189B2 (no)
KR (2) KR101503957B1 (no)
CN (2) CN104173371A (no)
AR (2) AR067929A1 (no)
BR (1) BRPI0814979A2 (no)
CA (1) CA2696062C (no)
CL (1) CL2008002366A1 (no)
DK (1) DK2194968T3 (no)
EA (1) EA017118B1 (no)
ES (2) ES2582871T3 (no)
GE (1) GEP20125539B (no)
HK (2) HK1143956A1 (no)
HU (1) HUE029713T2 (no)
MA (1) MA31678B1 (no)
ME (1) ME00975B (no)
MX (1) MX2010001533A (no)
NO (1) NO20100114L (no)
PE (1) PE20090939A1 (no)
PL (2) PL2194968T3 (no)
PT (2) PT2710998T (no)
SA (1) SA08290496B1 (no)
TN (1) TN2010000058A1 (no)
TW (2) TWI519303B (no)
UA (1) UA97408C2 (no)
WO (1) WO2009056703A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025332A1 (fr) * 2007-08-13 2009-02-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Composition thérapeutique aromatisée à base d'argile
FR2952814B1 (fr) * 2009-11-23 2013-07-19 Ephyla Sas Composition comprenant un complexe de phyllosilicates organiquement modifies generer des emulsions huile dans eau eventuellement a froid
WO2012095877A1 (en) 2011-01-12 2012-07-19 Sooft Italia Spa Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions
ITUA20162277A1 (it) * 2016-04-04 2017-10-04 Chemists Res Srl Composizione comprendente diosmectite
CN105902625A (zh) * 2016-05-26 2016-08-31 朱胜利 一种小儿止泻药的服用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707367A (en) * 1984-07-16 1987-11-17 Sunkist Growers, Inc. Solid essential oil flavor composition
WO1986000502A1 (en) * 1984-07-16 1986-01-30 Sunkist Growers, Inc. Solid essential oil flavor composition and method of manufacture
JPH064530B2 (ja) * 1985-02-23 1994-01-19 日本化薬株式会社 親水性基剤
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
WO1994023593A1 (en) * 1993-04-16 1994-10-27 Mccormick & Company, Inc. Encapsulation compositions
FR2770778B1 (fr) * 1997-11-12 2000-05-26 Investigations Therapeutiques Composition pour le traitement des gastro-enterites aigues, procede de fabrication de cette composition et solution de traitement obtenue a partir de cette composition
KR20030050958A (ko) * 2001-12-20 2003-06-25 송우영 디옥타헤드랄 스멕타이트를 유효성분으로 함유하는 항균성외용조성물
US8334007B2 (en) * 2003-03-19 2012-12-18 Firmenich Sa Continuous process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
CN100340235C (zh) * 2004-05-21 2007-10-03 山东绿叶制药有限公司 蒙脱石分散片及其制备工艺
EP1627573A1 (en) * 2004-08-20 2006-02-22 Firmenich Sa A process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
JP2006083071A (ja) * 2004-09-14 2006-03-30 Takasago Internatl Corp 香粧品用固形製剤
WO2007051427A1 (fr) * 2005-11-04 2007-05-10 Zhejiang Hailisheng Pharmaceutical Limited Co. Montmorillonite modifiee, son procede de preparation et ses utilisations
FR2901360A1 (fr) 2006-05-16 2007-11-23 Horiba Abx Sas Soc Par Actions Dispositif de conditionnement pour analyse biologique
EP2025332A1 (fr) * 2007-08-13 2009-02-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Composition thérapeutique aromatisée à base d'argile

Also Published As

Publication number Publication date
AR114148A2 (es) 2020-07-29
KR20100055460A (ko) 2010-05-26
HK1196271A1 (zh) 2014-12-12
EP2710998A1 (fr) 2014-03-26
ES2582871T3 (es) 2016-09-15
KR20140133617A (ko) 2014-11-19
US9056055B2 (en) 2015-06-16
MX2010001533A (es) 2010-03-15
WO2009056703A8 (fr) 2010-03-04
TW201509424A (zh) 2015-03-16
HK1143956A1 (en) 2011-01-21
KR101503957B1 (ko) 2015-03-18
PL2194968T3 (pl) 2013-10-31
EP2194968A1 (fr) 2010-06-16
TWI519303B (zh) 2016-02-01
JP2010535852A (ja) 2010-11-25
MA31678B1 (fr) 2010-09-01
EP2025332A1 (fr) 2009-02-18
GEP20125539B (en) 2012-05-25
CL2008002366A1 (es) 2009-05-29
JP5670189B2 (ja) 2015-02-18
US20100159013A1 (en) 2010-06-24
CA2696062C (fr) 2017-09-05
CA2696062A1 (fr) 2009-05-07
EP2710998B1 (fr) 2016-04-20
PT2194968E (pt) 2013-07-25
HUE029713T2 (en) 2017-03-28
TWI511734B (zh) 2015-12-11
PL2710998T3 (pl) 2016-11-30
EA017118B1 (ru) 2012-09-28
CN101778622A (zh) 2010-07-14
BRPI0814979A2 (pt) 2015-02-03
WO2009056703A1 (fr) 2009-05-07
TN2010000058A1 (fr) 2011-09-26
EP2194968B1 (fr) 2013-06-19
DK2194968T3 (da) 2013-09-02
CN104173371A (zh) 2014-12-03
PT2710998T (pt) 2016-07-28
US20140377354A1 (en) 2014-12-25
EA201070257A1 (ru) 2010-06-30
ME00975B (me) 2012-06-20
ES2421379T3 (es) 2013-09-02
SA08290496B1 (ar) 2012-11-03
UA97408C2 (ru) 2012-02-10
TW200914034A (en) 2009-04-01
JP2014208715A (ja) 2014-11-06
PE20090939A1 (es) 2009-07-27
AR067929A1 (es) 2009-10-28

Similar Documents

Publication Publication Date Title
DK2058317T3 (da) Aminophosphorsyreesterderivat og S1P receptormodulator indeholdende samme som aktiv ingrediens
CR10566A (es) Compuestos heterociclicos adecuados para el tratamiento de enfermedades relacionadas con nivel elevado de lipidos
MA32200B1 (fr) Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation
UY30477A1 (es) Derivados de [4,5']bipirimidinil-6,4´-diamina como inhibidores de cinasa de proteina
CL2007000522A1 (es) Compuestos derivados pirrolopiridina; composicion farmaceutica que la comprende; metodo para modular la actividad de una proteina quinasa; y metodo para tratar enfermedades mediada por la actividad de proteinas quinasas.
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
HN2005000255A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
EP2078731A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
EP2045253A4 (en) alpha-amino acid derivative and pharmaceutical agent containing it as an active ingredient
BRPI0807285A2 (pt) "composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto"
FR2915683B1 (fr) Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
EP2142549A4 (en) ADENOSINE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES THEREOF CONTAINING THEM AS AN ACTIVE SUBSTANCE
NO20100114L (no) Smakstilsatt leirebasert farmasoytisk preparat
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
UY29445A1 (es) Composiciones para la transmisión transmucosa oral de la metformina
NO20071806L (no) Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel.
NO20092763L (no) Isosorbid mononitrat derivater for behandling av tarmlidelser
ITMI20051231A1 (it) Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale
UY31662A1 (es) Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de elaboracion.
NZ595469A (en) Sublingual spray formulation comprising dihydroartemesinin
DK1666473T3 (da) Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens
WO2006138431A3 (en) Methods and pharmaceutical formulations for increasing bioavailability

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application